vated free T4, a suppressed thyrotropin level and positivity for anti-thyroid receptor antibodies. Vitiligo has been previously reported as a symptom of polyglandular autoimmune syndrome type 2, and the condition has also been associated with autoimmune diseases such as Graves' disease, adrenal insufficiency, pernicious anemia, lupus and diabetes. Recently, a genetic analysis has enabled the identification of certain shared susceptibility genes that may cause these diseases, such as the genetic polymorphisms that are located in the locus of NALP1 inflammasomes on chromosome 17 (1) . Despite the lack of genetic confirmation, the simultaneity of the onset of both vitiligo and Graves' disease suggests that they may develop as expressions of a shared susceptibility gene. An awareness of this association may aid in the early diagnosis of other latently coexisting and potentially fatal autoimmune diseases (2) .
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